It is so close I can feel it.

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 1283 Last

Share
Profile

Follow
BWinter

2,627 Posts.

307

29/08/18

17:49

Post #: 35272823
Share

Originally posted by Tiredandhungry ↑

Hey Guys,

Sent some emails to confirm schedule as some have speculated on here. The first answer is basically a copy paste of what another user on here posted which is fair enough given how busy they must be. The second answer I believe just refers to the first to explain why US results take longer than AUS but does not answer my question as to why the results will be later than expected (although it seems they will be early September).

Emails in order:

Q:
Hi,

I am a shareholder in Resapp Health, I was hoping you would be able to clarify whether the results of both the Breathe Easy and Smartcough-C-2 clinical trials are still planned for release this week?

Thanks,

A:

My understanding is that results are due at the end of this month. With that in mind, I expect that US results will likely come after Australian results for two reasons:

1. There are twice as many patients in the US study than the Australian study that need final adjudication.

2. The adjudication panel is made up of doctors in three different US States that have to meet on multiple occasions. The Australian study has a panel of doctors that are all based in Perth.

Regards

Q:

Thank you for the quick response Brian,

Just to clarify, the US results are still expected this month? If they are expected later than this month, are there any reasons for the delays given that they were stated to be due this month in the August 1st announcement of completed enrollment and that similar trials had been completed last year giving the company a good idea of the timeframe to complete such trials.

Thanks again,

A:

I expect Aus results by the end of this month. US results may also come then but if they come shortly afterwards its for the reasons outlined below. Aus results will be used for TGA and CE approvals. US results for FDA approval.

Expand

It is so close I can feel it.

RAP Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

First 1283 Last

Add RAP (ASX) to my watchlist

It is so close I can feel it.

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News